Prevalence of Dyspnea Among Hospitalized Patients at the Time of Admission

Journal of Pain and Symptom Management
Jennifer P StevensRobert B Banzett

Abstract

Dyspnea is an uncomfortable and distressing sensation experienced by hospitalized patients. There is no large-scale study of the prevalence and intensity of patient-reported dyspnea at the time of admission to the hospital. Between March 2014 and September 2016, we conducted a prospective cohort study among all consecutive hospitalized patients at a single tertiary care center in Boston, MA. During the first 12 hours of admission to medical-surgical and obstetric units, nurses at our institution routinely collect a patient's 1) current level of dyspnea on a 0-10 scale with 10 anchored at "unbearable," 2) worst dyspnea in the past 24 hours before arrival at the hospital on the same 0-10 scale, and 3) activities that were associated with dyspnea before admission. The prevalence of dyspnea was identified, and tests of difference were performed across patient characteristics. We analyzed 67,362 patients, 12% of whom were obstetric patients. Fifty percent of patients were admitted to a medical-surgical unit after treatment in the emergency department. Among all noncritically ill inpatients, 16% of patients experienced dyspnea in the 24 hours before the admission. Twenty-three percent of patients admitted through the emergency depart...Continue Reading

References

Aug 1, 1990·Archives of Internal Medicine·K KroenkeA D Mangelsdorff
Feb 7, 1998·Medical Care·A ElixhauserR M Coffey
Jun 11, 1999·European Journal of Cancer Care·M O'DriscollC Bailey
Feb 15, 2001·Heart & Lung : the Journal of Critical Care·M B ParshallK B Cassidy
Apr 25, 2001·Journal of General Internal Medicine·C S WeisseB L Syat
Jan 1, 1964·American Journal of Public Health and the Nation's Health·E C HAMMOND
Apr 7, 2004·Archives of Gerontology and Geriatrics·Ali AhmedJames F DeLong
May 21, 2005·Journal of Pain and Symptom Management·Barbara StrohbueckerRainer Sabatowski
Nov 4, 2005·The New England Journal of Medicine·Aiden AbidovDaniel S Berman
Feb 15, 2007·Journal of Palliative Medicine·Martha L TwaddleJoanne Cuny
Apr 29, 2008·Occupational Medicine·Chris Stenton
Aug 17, 2010·Critical Care Medicine·Kathleen A PuntilloChristine Miaskowski
Jan 24, 2012·Chest·Paula M MeekRobert Lansing
Feb 18, 2012·American Journal of Respiratory and Critical Care Medicine·Mark B ParshallUNKNOWN American Thoracic Society Committee on Dyspnea
Oct 12, 2013·The American Journal of Nursing·Kathy BakerRobert Banzett
Dec 3, 2014·Chest·Jennifer P StevensMichael D Howell
Mar 21, 2015·The European Respiratory Journal·Robert B BanzettRobert W Lansing
Apr 8, 2016·MMWR. Morbidity and Mortality Weekly Report·Lauren EpsteinAnthony Fiore
Feb 10, 2017·The European Respiratory Journal·Marie T WilliamsPeter Frith
Mar 4, 2017·The European Respiratory Journal·Robert B Banzett, Shakeeb H Moosavi

❮ Previous
Next ❯

Citations

Dec 12, 2018·Current Opinion in Critical Care·Maxens DecavèleAlexandre Demoule
Sep 17, 2018·The European Respiratory Journal·Dan Adler
May 31, 2019·Current Opinion in Supportive and Palliative Care·Marie T Williams, Kylie N Johnston
Feb 14, 2020·Journal of Renal Care·Maria ChilversMarie T Williams
Nov 30, 2018·American Journal of Respiratory and Critical Care Medicine·Eliza R GentzlerHolly G Prigerson
Apr 16, 2021·European Clinical Respiratory Journal·Charlotte Sandau BechIngrid Poulsen
Mar 4, 2021·The European Respiratory Journal·Jennifer P StevensRobert B Banzett
Sep 4, 2021·The European Respiratory Journal·Maxens Decavèle, Thomas Similowski
Nov 21, 2021·Clinical Journal of Oncology Nursing

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.